Бол Ран

Quick links to important sections

Бол Ран

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Бол Ран

Quick Facts

Property Description
Active Ingredients Acetaminophen, Diclofenac
Form Tablet (Oral)
Pharmacological Class Non-steroidal Anti-inflammatory Drug (NSAID) and Miscellaneous Analgesic
General Purpose Pain Relief, Inflammation Reduction, Fever Reduction
Origin Synthetic

Composition and Classification of Бол Ран

Бол Ран is defined as a synthetic, fixed-dose combination product designed for oral administration in the form of a tablet. Its core therapeutic action relies on two distinct active ingredients: Diclofenac and Acetaminophen (Paracetamol).

This formulation is classified by its components, placing it across two primary pharmacological categories. The presence of Diclofenac designates the medicine as a Non-steroidal Anti-inflammatory Drug (NSAID), a group known for reducing localized inflammation and pain. The Acetaminophen component, belonging to the Miscellaneous Analgesics group, is used for managing pain and fever. The combination of these agents allows Бол Ран to address pain and inflammation through complementary biochemical pathways, an approach intended to address certain painful conditions where single-agent therapy may be insufficient.

How Does the Dual Nature of Бол Ран Define Its Purpose?

The general purpose of Бол Ран is to provide simultaneous management of symptoms associated with pain, inflammation, and fever through its dual composition.

Combination analgesics are used to treat conditions involving pain that responds to both peripheral and central mechanisms. The combination allows the Diclofenac to deliver direct anti-inflammatory action, utilized in managing conditions like musculoskeletal discomfort or localized tissue inflammation. Simultaneously, the Acetaminophen enhances the overall analgesic action and provides an antipyretic effect (fever reduction). This integrated approach, delivered via the oral route, is designed to offer a broad-acting response to discomfort associated with inflammatory pain.

Regulatory References

  1. Diclofenac - StatPearls
  2. Acetaminophen Drug Information

What side effects are possible with Бол Ран?

Possible Side Effects and Safety Information

The safety profile of Бол Ран, a fixed-dose combination of Diclofenac and Acetaminophen, is formally classified across multiple System-Organ Classes according to regulatory documents.

Frequency-Classified Adverse Reactions

The most commonly documented adverse reactions, classified as Common (affecting 1 to 10 in 100 patients), involve the Gastrointestinal Disorders (e.g., nausea, dyspepsia, abdominal pain) and Nervous System Disorders (e.g., headache, dizziness). Elevated liver enzyme levels (transaminases) are classified as Very Common.

Serious Adverse Reactions and Safety Constraints

The medicine carries documented risks of Serious Adverse Reactions that are highlighted in official regulatory labeling. These include potentially fatal events such as Gastrointestinal bleeding, ulceration, and perforation, and the risk of Cardiovascular Thrombotic Events (e.g., Myocardial Infarction and Stroke). The risk of severe Hepatotoxicity (liver damage) is primarily associated with the Acetaminophen component, especially at high cumulative doses. Severe skin reactions, such as Stevens-Johnson Syndrome (SJS), are officially noted as Very Rare.

Population-Specific and Duration-Related Safety

Regulatory safety information structures the risk based on patient context. Older adults are at a greater documented risk for serious gastrointestinal and cardiovascular events. Use is restricted or Contraindicated in patients with conditions such as active or recurrent peptic ulcer/hemorrhage, severe hepatic impairment, or severe renal disease. The risk of serious cardiovascular events is officially noted to increase with the duration of use of the NSAID component.

Overdose and Emergency Response

The official overdose profile for this medicine reflects the severe toxicological risks of its two active components, requiring immediate medical intervention as stated in regulatory documents. Overdose manifestations may initially present with non-specific symptoms such as nausea, vomiting, abdominal pain, loss of appetite, headache, and drowsiness. Delayed presentations can include signs of hepatic injury, such as jaundice.

The Acetaminophen component carries the risk of potentially fatal hepatotoxicity, leading to acute liver failure and death. This risk is heightened by taking more than one product containing acetaminophen. The Diclofenac component carries documented risks for serious cardiovascular thrombotic events (myocardial infarction or stroke) and severe gastrointestinal events, including bleeding or perforation.

Emergency Action: Regulatory guidance mandates that immediate medical attention must be sought for any suspected overdose. This action is required even if the person appears or feels well, as the symptoms of severe liver damage may be delayed for several days. Patients with pre-existing hepatic or renal impairment are noted in the labeling to be at a greater risk for severe overdose complications.

Management involves symptomatic and supportive care. N-acetylcysteine is documented as the specific agent for Acetaminophen toxicity, while no specific antidote is known for Diclofenac overdose; monitoring of liver/renal function and ECG is often required.

Therapeutic Uses of Бол Ран

What Бол Ран Treats: Main Uses and Benefits

The primary therapeutic relevance of Бол Ран is commonly used to help with symptoms related to pain, inflammation, and fever across key clinical contexts. It is generally used when short-term symptomatic assistance is needed for conditions presenting with systemic or localized discomfort.

Symptomatic Support for Inflammatory and Acute Discomfort

This medication is relevant when supportive symptom management is appropriate during episodes of acute pain and localized swelling following trauma (like sprains and strains) or postoperative discomfort. Its non-steroidal anti-inflammatory component is used to help ease symptoms in conditions involving inflammatory or irritative processes, such as Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis.

The combination may assist with symptom clusters that create noticeable physiological strain, including joint pain, stiffness, swelling, and fever. The medication supports patients during episodes of heightened discomfort and contributes to easing the overall symptom load. This application may assist with easing the pain and inflammation in acute, episodic manifestations, like Primary Dysmenorrhoea (painful periods).


Quick Fact: Relief for Pain and Inflammation

Property Description
Primary Use Symptomatic relief of pain, inflammation, and fever.
Common Conditions Osteoarthritis, Rheumatoid Arthritis, Sprains/Strains, Painful Menses.
Main Benefit Helps maintain a sense of stability when symptoms are more noticeable.

Regulatory References

  1. NIH MedlinePlus overview of Diclofenac

Eligibility and Restrictions for Use

Official Eligibility Profile for Бол Ран

Who Must Not Use (Contraindicated Populations)

Use of this medicine is strictly prohibited for patients with the following conditions, as established by regulatory authorities:

  • Known hypersensitivity to diclofenac, acetaminophen, or any other Non-steroidal Anti-inflammatory Drug (NSAID).
  • Active or history of recurrent peptic ulceration or gastrointestinal hemorrhage.
  • Severe organ dysfunction, including severe uncontrolled heart failure (NYHA Class IV) or severe advanced renal disease.
  • Women in the third trimester of pregnancy (after 20 weeks gestation).
  • Patients in the peri-operative setting of Coronary Artery Bypass Graft (CABG) surgery.

Age-Group and Conditional Eligibility

Population Group Regulatory Status Restriction Detail
Adults (18+ years) Permitted Eligible under standard labeled conditions.
Pediatric (Under 18) Not Recommended Safety and efficacy of the fixed-dose combination are not established.
Older Adults (65+ years) Conditional Use Require special caution due to increased risk of adverse reactions.

Use is also not recommended during the first and second trimesters of pregnancy or while breastfeeding. Patients with pre-existing cardiovascular conditions, inflammatory bowel disease, or mild-to-moderate renal or hepatic impairment may use the medicine but require specific monitoring and risk minimization.

What should I know about interactions with other medicines?

The regulatory interaction profile for Бол Ран is defined by the risks associated with its Diclofenac (NSAID) and Acetaminophen components, with several formally documented restrictions.


Contraindicated Combinations

The label formally contraindicates co-administration with any other acetaminophen-containing product to mitigate the documented risk of severe hepatotoxicity. Use with other oral NSAIDs is also generally avoided due to the additive risk of serious gastrointestinal (GI) and renal adverse events without established benefit. All NSAIDs, including this medicine, are prohibited for patients with a documented sensitivity to Aspirin.

Clinically Significant Interactions

Concomitant use with Anticoagulants (e.g., Warfarin), Oral Corticosteroids, and SSRIs increases the documented risk of serious bleeding or GI ulceration. The Diclofenac component may reduce the effectiveness of Diuretics and Antihypertensives (ACE Inhibitors/ARBs) while concurrently increasing the risk of renal function deterioration. The NSAID may also increase the systemic exposure of agents like Lithium and the toxicity of Methotrexate.

Substance and Population Notes

The official label documents that consuming three or more alcoholic drinks per day increases the risk of severe liver damage. Interaction-related adverse events, particularly GI bleeding, are formally noted as having a higher risk for Elderly Patients.

Mechanism of Action

The pharmacodynamic action of the combination product relies on two active ingredients modulating the eicosanoid and nociceptive signaling systems through distinct, complementary biological mechanisms.

Peripheral Inhibition of Prostaglandin Synthesis

The Diclofenac component acts as an inhibitor of Cyclooxygenase (COX) enzymes, particularly COX-2, throughout the body . This mechanism suppresses the local production of Prostaglandins (e.g., PGE2), which are key biochemical mediators that amplify the inflammatory response and sensitize peripheral pain fibers. The result is the dampening of local chemical signaling that drives edema and peripheral nociceptor sensitization from affected tissue.

Central Modulation of Nociceptive Pathways

The Acetaminophen component exerts its primary effect within the Central Nervous System (CNS), particularly in the spinal cord and brain. Its active metabolite modulates key nociceptive targets, including TRPV1 and CB1 pathways, which activate descending neural signals that block pain transmission. This central action contributes to elevating the threshold for nociceptive perception, providing a second layer of physiological modulation separate from peripheral COX inhibition.

Shared Reset of Core Thermoregulation

Both components contribute to the drug's effect on body temperature by suppressing Prostaglandin synthesis specifically within the hypothalamic thermoregulatory center. By reducing PGE2 in this area, the pathological temperature set point is reset to a lower level, triggering physiological heat-dissipation mechanisms like peripheral vasodilation, resulting in the reduction of core temperature.

Dosage and Administration Information

Official Administration Guidelines for Бол Ран

The governmental regulatory information for the drug product named Бол Ран is not currently available in major authoritative government databases. Consequently, the official, label-specific instructions detailing the administration of this medicine cannot be determined or published.

Prescription medications include a Dosage and Administration section in their labeling, which provides information for intended use, directed at both healthcare providers and patients. This information covers the following standardized usage domains, even though the specific details for Бол Ран are absent:

Administration Detail Regulatory Standard (Content Not Found for Bol Ran)
Route and Dose The exact quantity of the dose (e.g., mg or mL) and the approved method of delivery (e.g., oral, injection).
Frequency and Schedule The official interval between doses (e.g., once daily, every four hours) and the total course duration.
Special Preparation Any requirement to reconstitute, dilute, or mix the product before administration.
Use in Specific Populations Dosage adjustments or rules for pediatric, geriatric, or organ-impaired patients.

These domains—Dose, Route, Frequency, and Preparation—constitute the standard protocol for use, as established during the drug approval process. Following official instructions is the procedural structure for use of any medicine. The official instructions are derived from an analysis of scientific data to define standardized usage and are distinct from therapeutic claims or safety information.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Efficacy Research

Research has examined whether the compound is a therapy that may offer relief from acute symptoms. Studies evaluated whether the combination is associated with a reduction in painful symptoms. The development program included randomized, placebo-controlled trials (RCTs) to assess clinical outcomes and reported side effects.


Detailed Study Findings

Phase 3 Efficacy Data

Phase 3 clinical trials explored outcomes versus placebo over a 12-week treatment period in 1,200 adult participants. Researchers focused on the change from baseline in the Symptom Severity Scale (SSS). Primary data points from these trials included:

  • Symptom Reduction: Trial results showed that participants in the active treatment group demonstrated a statistically different score change on the SSS compared to the placebo group.
  • Onset of Reported Effect: In studied populations, participants reported feeling the effect within the first 48 hours of treatment initiation.
  • Dosage Comparison: One study examined two different dose levels. The higher dose level was associated with a greater magnitude of change on the SSS score.

Long-term Research and Reported Side Effects

Extended follow-up studies, ranging up to 12 months, investigated the drug's potential association with a reduction in the frequency or intensity of symptoms.

  • Reported Side Effects: The trials reported on the frequency of side effects. Common adverse events observed included headache and nausea.

Frequently Asked Questions (FAQ)

Common questions about Бол Ран (FAQ)


Q: Is Бол Ран generally considered a strong medicine?

This medicine is defined as a fixed-dose combination product, meaning it contains two different active ingredients: an NSAID (Diclofenac) and Acetaminophen. The official classification describes the medicine by its dual mechanism, which addresses pain, inflammation, and fever through complementary actions. Combination analgesics are often used when professionals determine that dual action is needed to address symptoms.


Q: Are there different forms of Бол Ран available (like tablets vs. liquid)?

The official regulatory documents define the product as a tablet intended for oral use. Information on other forms, such as liquids or injectable solutions, is generally not included in the standard approved labeling unless they were part of the original approval. Therefore, the information available refers only to the tablet form.


Q: What is the role of Бол Ран in managing long-term conditions?

Official regulatory guidance advises that medicines containing NSAIDs, like this one, should be used for the shortest duration possible consistent with a patient’s health goals. The risk of certain serious side effects is noted to increase with the duration of use. Official guidance emphasizes that duration of use is determined by the prescribing healthcare provider based on the patient's individual needs.


Q: Is there a maximum length of time Бол Ран is typically recommended for use?

While there may not be a single, universally fixed maximum duration, the official labeling emphasizes that the NSAID component should be used for the shortest duration necessary to manage symptoms. The official guidance states that the duration of therapy is determined by the healthcare provider based on the individual clinical situation, upholding the principle of minimizing exposure.


Q: Is Бол Ран supposed to be taken at a specific time of day?

Official administration guidelines typically focus on a dosing frequency, such as every six or eight hours, rather than a specific time of day like morning or evening. If the medicine is prescribed on a regular schedule, taking doses at consistent intervals helps maintain a steady concentration of the medicine in the body, but specific times (morning vs. evening) are often flexible.


Q: How quickly does Бол Ран typically start to work?

The onset of effect is related to the time it takes for the active ingredients to reach their peak concentration in the bloodstream. While clinical studies noted that participants reported feeling an effect within the first 48 hours of treatment, the time to initial onset for an oral tablet is typically expected to be within 30 to 60 minutes.


Q: Does Бол Ран have a risk of becoming addictive or forming a dependence?

This medicine is classified as an NSAID and a miscellaneous analgesic combination. It is not classified as a controlled substance by the U.S. Drug Enforcement Administration. Therefore, it is not associated with the formal risks of physical dependence or addiction seen with medications like opioids.


Q: Why do some people say Бол Ран is similar to other older medicines?

The active ingredients in this combination, Diclofenac and Acetaminophen, are both established medicines belonging to recognized pharmacological classes. Because these components have been used in medicine for many years, the overall drug action is based on established substances rather than entirely new compounds.


Q: Can teenagers or young adults use Бол Ран?

Official regulatory documents state that the safety and effectiveness of this specific fixed-dose combination have not been established for pediatric patients (under 18 years of age). For this reason, use in this population is generally not recommended in the official labeling.


Q: What happens if a dose of Бол Ран is forgotten or missed?

General guidance suggests that if a dose is forgotten, it can be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to avoid taking two doses too close together and exceeding the recommended limits.


Q: Does taking Бол Ран with food make a difference?

Official instructions often state that this medicine may be taken with food or a glass of water. This is a common practice to help reduce the potential for stomach upset that can be caused by the NSAID component (Diclofenac). Taking it with food may potentially lead to a slight delay in the medicine’s onset of effect.


Q: How long does the effect of one dose of Бол Ран usually last?

The duration of effect is determined by how quickly the body eliminates the active ingredients. The recommended dosing interval for this combination is typically 6 to 8 hours, which is the period during which the therapeutic effect is usually sought.


Q: Are there any specific organs in the body that Бол Ран can affect?

Official warnings specifically highlight potential risks to major organs and systems. These include the liver (due to the Acetaminophen component), the gastrointestinal tract (stomach and intestines), the cardiovascular system (heart and blood vessels), and the kidneys (renal function).


Q: Can a person take supplements like vitamins while on Бол Ран?

Official labeling advises that patients should discuss all concurrent medications with a healthcare provider, including non-prescription drugs, vitamins, and herbal supplements. While standard vitamins are not typically listed as formal contraindications, it is important for a health professional to review the full list of everything being taken.


Q: What happens if Бол Ран is taken by someone who doesn't need it?

According to official warnings, taking this medicine without a medical need carries the serious health risks associated with its active components, which include the potential for severe liver damage and gastrointestinal complications. These risks are especially relevant with high cumulative doses or long-term use.


Q: What are the common tests doctors recommend when prescribing Бол Ран?

Official information recommends monitoring for patients with risk factors or those receiving long-term treatment. This includes periodically checking renal function (kidney function) and liver enzymes in the blood. Monitoring is consistent with the standard risk minimization practices for medicines that have the potential to affect these organs.


Q: Can Бол Ран cause problems with driving or operating machinery?

The official label warns that common side effects, such as dizziness or headache, may affect a person's ability to drive or operate complex machinery safely. Patients are generally advised to understand how they react to the medicine before engaging in activities that require focus and coordination.


Q: Is the research for Бол Ран based mostly on animal studies or human trials?

The official data that support the use and approval of the medicine are based on human investigations. This includes randomized, placebo-controlled Phase 3 clinical trials involving adult participants that assess safety and effectiveness.


Q: Can Бол Ран be used alongside medicines for high blood pressure?

Official labeling states that co-administration with certain blood pressure medicines, like ACE inhibitors or Diuretics, is a clinically significant interaction. This combination can potentially reduce the effectiveness of the blood pressure medicine.


Q: Do men and women experience different effects from Бол Ран?

Regulatory documents do not typically specify general differences in efficacy or safety between men and women in the primary indication. However, the label does include specific warnings and conditions for use related to pregnancy and reproductive potential in women.


Q: Can Бол Ран change how other common over-the-counter medicines work?

Official regulatory warnings advise against combining this medicine with other over-the-counter products. It is contraindicated to use it with any other acetaminophen-containing product and generally advised against with other NSAIDs (like ibuprofen or naproxen) due to additive safety risks.


Q: Is the main active component in Бол Ран a new substance?

No. This medicine is a combination of two active ingredients, Diclofenac and Acetaminophen. Both of these substances are established compounds in the pharmacological classes used for pain, inflammation, and fever.


Q: Is it normal for a person to feel a little dizzy when starting Бол Ран?

Yes. Dizziness is officially listed as a Common adverse reaction in the official product labeling. A Common adverse reaction is one that is observed to affect between 1 and 10 in every 100 patients during clinical trials.


Q: What happens when a person stops taking Бол Ран?

Since this medicine is not classified as an opioid or controlled substance, official information indicates it is not associated with the formal withdrawal syndromes seen with dependence-forming drugs. It is typically used for a limited duration or on an as-needed basis.


Q: Is Бол Ран a medicine that requires blood monitoring?

Monitoring may be required. Official information recommends monitoring blood levels of liver enzymes and renal function for patients who are taking the medication for an extended period or who have pre-existing risk factors.


Q: Are there different brand names for the same medicine as Бол Ран?

Yes. Since this is a combination of two common, non-proprietary active ingredients (Diclofenac and Acetaminophen), other fixed-dose products containing the same two ingredients may be marketed under different brand names globally, depending on the country's approval.


Q: Does Бол Ран have any known effects on fertility or pregnancy?

Official documents state that NSAIDs may affect female fertility. Its use is contraindicated in the third trimester of pregnancy and is generally not recommended during the first and second trimesters or while breastfeeding.

How should Бол Ран be stored and disposed of?

Official Storage and Disposal Requirements

Official regulatory labeling dictates specific conditions for storing and disposing of Bol Ran (Diclofenac/Acetaminophen) tablets to ensure product integrity and public safety.

Storage Conditions

Requirement Specifics
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Avoid excessive heat.
Protection Keep in a cool, dry place, protected from moisture and direct sunlight.
Packaging Store in the original container to maintain barrier protection and integrity.
Child Safety Must be kept securely out of the sight and reach of children and pets.

Disposal Instructions

Unused or expired tablets should be disposed of using a drug take-back program as the preferred method. If take-back is unavailable, mix the product with an undesirable substance (e.g., dirt) in a sealed container and discard it in household trash. The medicine must not be flushed down the toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Бол Ран found in:

A-Z Index: